Addus HomeCare (NASDAQ:ADUS) Upgraded to “Strong-Buy” at Citizens Jmp

Citizens Jmp upgraded shares of Addus HomeCare (NASDAQ:ADUSFree Report) to a strong-buy rating in a research note published on Monday,Zacks.com reports.

A number of other equities research analysts also recently weighed in on ADUS. Royal Bank of Canada restated an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. Oppenheimer lifted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. Stephens increased their price objective on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. JMP Securities started coverage on Addus HomeCare in a research note on Monday. They set an “outperform” rating and a $150.00 price objective for the company. Finally, StockNews.com raised Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $133.67.

View Our Latest Analysis on Addus HomeCare

Addus HomeCare Trading Up 0.2 %

Shares of NASDAQ ADUS opened at $130.73 on Monday. The company has a market capitalization of $2.37 billion, a price-to-earnings ratio of 29.92, a price-to-earnings-growth ratio of 2.11 and a beta of 1.01. The business has a 50 day simple moving average of $125.76 and a 200-day simple moving average of $124.69. Addus HomeCare has a twelve month low of $85.94 and a twelve month high of $136.12.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.03 earnings per share. As a group, equities analysts predict that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Activity at Addus HomeCare

In related news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,236,257. This represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Connor Clark & Lunn Investment Management Ltd. bought a new position in Addus HomeCare in the third quarter valued at approximately $1,622,000. Dimensional Fund Advisors LP boosted its position in shares of Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after purchasing an additional 5,421 shares during the last quarter. Argent Capital Management LLC grew its stake in shares of Addus HomeCare by 51.5% during the second quarter. Argent Capital Management LLC now owns 37,310 shares of the company’s stock worth $4,332,000 after purchasing an additional 12,685 shares during the period. Point72 Asset Management L.P. increased its holdings in Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after purchasing an additional 315,602 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its stake in Addus HomeCare by 136.5% in the second quarter. Victory Capital Management Inc. now owns 80,047 shares of the company’s stock valued at $9,294,000 after buying an additional 46,199 shares during the period. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.